|
|
.
See Category: Factors influencing health status and contact with health services
ICD-10 (CM) Code and Descriptor
|
Z42.1 |
Encounter for breast reconstruction following mastectomy
Age 14 and up.
|
Z421 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 78.35%
|
7.27%
|
5.29%
|
2.90%
|
1.83%
|
1.16%
|
0.83%
|
0.62%
|
0.40%
|
0.31%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for Z42.1*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
2,092
|
9,253
|
|
J3010
|
FENTANYL CITRATE INJECTION |
2,065
|
4,135
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
1,978
|
69,647
|
|
J2405
|
ONDANSETRON HCL INJECTION |
1,916
|
8,850
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
1,591
|
11,123
|
|
C1789
|
PROSTHESIS, BREAST, IMP |
1,306
|
2,088
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
1,264
|
2,590
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
1,251
|
10,412
|
|
J7120
|
RINGERS LACTATE INFUSION |
1,075
|
1,630
|
|
J1170
|
HYDROMORPHONE INJECTION |
971
|
1,569
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
940
|
13,640
|
|
J1580
|
GARAMYCIN GENTAMICIN INJ |
771
|
1,201
|
|
11970
|
RPLCMT TISS XPNDR PERM IMPLT |
769
|
769
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
696
|
696
|
|
15772
|
GRFG AUTOL FAT LIPO EA ADDL |
623
|
781
|
|
J2001
|
LIDOCAINE INJECTION |
572
|
8,068
|
|
J2370
|
PHENYLEPHRINE HCL INJECTION |
571
|
2,512
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
543
|
769
|
|
J0171
|
ADRENALIN EPINEPHRINE INJECT |
527
|
6,330
|
|
19342
|
INSJ/RPLCMT BRST IMPLT SEP D |
514
|
514
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
Z42.1 related to the following DRG Codes:
606-607
|
